The Glucosamine Market is Predict to reach USD 1.3 Billion by 2030, at a CAGR of 5%

31-Jan-2024 | Report Format: Electronic (PDF)

Glucosamine Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Glucosamine Market size is expected to reach $1.3 billion by 2030, rising at a market growth of 5.0% CAGR during the forecast period. In the year 2022, the market attained a volume of 75,149.87 Tonnes, experiencing a growth of 4.2% (2019-2022).

The Supplement segment is generating highest revenue in the Global Glucosamine Market by Application in 2022; thereby, achieving a market value of $954.8 Million by 2030. The supplement segment has seen advancements in formulations, including the development of more bioavailable versions of glucosamine through advanced delivery systems such as nanotechnology, liposomal delivery, and microencapsulation. Advancements in the supplement industry include the ability to create customized formulations, allowing manufacturers to combine glucosamine with other joint-supporting ingredients, vitamins, or minerals.

The Glucosamine Hydrochloride segment is experiencing a CAGR of 5.5% during (2023 - 2030). Glucosamine hydrochloride is often chosen as a shellfish-free alternative, addressing concerns about shellfish allergies. The availability of a non-shellfish-derived option broadens the market reach of glucosamine, attracting individuals with specific dietary restrictions or allergies. Glucosamine hydrochloride is available in various supplement formulations, including capsules, tablets, and powders. Athletes and fitness enthusiasts embrace glucosamine hydrochloride as a preventive measure against joint stress and injuries.

Full Report: https://www.kbvresearch.com/glucosamine-market/

The Asia Pacific region dominated the Global Glucosamine Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $607.1 Million by 2030. The North America region is anticipated to grow at a CAGR of 4% during (2023 - 2030). Additionally, The Europe region would witness a CAGR of 4.8% during (2023 - 2030).

List of Key Companies Profiled

  • Teva Pharmaceutical Industries Ltd.
  • Laboratoires Expanscience S.A.
  • Nutramax Laboratories, Inc.
  • Amway Corporation
  • CellMark AB
  • Alfa Chemical Group
  • Cargill, Incorporated
  • Simply Supplements
  • Reckitt Benckiser Group PLC
  • Panvo Organics Pvt Ltd.

Glucosamine Market Report Segmentation

By Application (Volume, Tonnes, USD Billion, 2019-2030)

  • Supplement
  • Food & Beverage
  • Others

By Product (Volume, Tonnes, USD Billion, 2019-2030)

  • Glucosamine Sulfate
  • Glucosamine Hydrochloride
  • N-acetyl Glucosamine
  • Others

By Geography (Volume, Tonnes, USD Billion, 2019-2030)

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale